Learning Tracks

Drug shortages can be a challenge for manufacturers, providers, and most importantly, patients. Though drug shortages are certainly not limited to generic markets, generic drugs appear particularly susceptible. While each drug shortage is unique, most stem from the increasing fragility and challenges to the long-term sustainability of the generic drug market. This panel will discuss the key drivers of shortages with a focus on the generic market, implications of those shortages to providers and patients, and potential policy proposals to ensure the long-term sustainability of the generic drug market.

Moderator: David Kendall
Senior Fellow for Health and Fiscal Policy, Third Way

Shana Christrup
Senior Director, Policy, AAM

Elizabeth Gallenagh
General Counsel and Senior Vice President, Supply Chain Integrity, Healthcare Distribution Alliance

Tom Kraus
Vice President, Government Relations, ASHP

Polly Webster, JD, MPH
Senior Health Counsel, Senate Committee on Finance